For many people, type 2 diabetes can be put into remission, which means a blood sugar in the normal range, an HbA1c below 6.5%, held for at least three months after stopping all diabetes medication. Doctors say remission rather than cure, because the disease can come back if weight is regained. The strongest proof comes from the DiRECT trial, where a structured weight-loss program put about 46% of people into remission at one year, and the more weight someone lost, the more likely it was, reaching about 86% among those who lost 15 kilograms or more. Remission is most achievable early in the disease, before too much insulin-making capacity is lost. Normal sugars while taking a drug like Ozempic is control rather than remission by the formal definition, because the drug is doing the work. Remission is achievable but not permanent, so it needs ongoing attention.
TL;DR: For a meaningful share of people, type 2 diabetes can be pushed into remission, meaning a normal blood sugar, an HbA1c below 6.5%, sustained for at least three months after stopping all glucose-lowering medication. Doctors use the word remission rather than cure, because the disease can return if the weight comes back. The clearest proof is the DiRECT trial, a primary-care study in which a structured weight-loss program put about 46% of people into remission at one year, with the odds rising sharply the more weight was lost, up to about 86% among those who shed 15 kilograms or more. The leading explanation is that losing enough weight clears fat out of the liver and pancreas and lets the body make its own insulin again. Remission is most likely early in the disease, in people who have had diabetes for fewer years and still make a fair amount of insulin. One important point of confusion: normal sugars while you are taking a drug like Ozempic or Mounjaro is control rather than remission, because the medication is doing the work. And remission is not a permanent cure, so keeping the weight off and staying monitored is the hard, essential part. This is about type 2 diabetes; type 1 is a different, autoimmune disease that cannot be reversed this way.
Can type 2 diabetes really be reversed?
For many people, yes, in the sense that the blood sugar can return to a normal range and stay there without medication. That outcome has a specific name, remission, and understanding the word is the whole point, because it is both more hopeful and more honest than the alternatives.
Doctors avoid the word cure, because a cure implies the disease is gone for good, and type 2 diabetes can come back if the weight that drove it returns. They also tend to avoid reverse as a clinical term, even though it is common in everyday speech, because it is vague about whether the change lasts or whether medication is still involved. Remission is the agreed term, and it has a precise meaning that keeps everyone honest about what has and has not happened.
What does remission mean?
In 2021, an international group of experts, convened by the American Diabetes Association together with the European and UK diabetes bodies, set a single clear definition.1 Remission of type 2 diabetes means an HbA1c below 6.5%, the threshold used to diagnose diabetes in the first place, measured at least three months after stopping all glucose-lowering medication.
Two parts of that definition carry the weight. The first is the three months off medication. Remission is not about having good numbers on a drug; it is about the body holding a normal blood sugar on its own, which is why the clock only starts after the medication stops. The second is the durability implied by the word: remission describes a state that is being maintained rather than a single lucky lab result, so it is confirmed and then rechecked over time. HbA1c, the marker used, reflects the average blood sugar over about three months, which makes it the right yardstick for a lasting change rather than a daily fluctuation.
What proved it was possible? The DiRECT trial
The evidence that changed the conversation is the DiRECT trial, run in ordinary UK primary-care practices and led by Michael Lean and Roy Taylor. It tested whether a structured weight-loss program, delivered by regular nurses and dietitians, could put type 2 diabetes into remission.
The program was intensive. People replaced all their food with a low-calorie formula diet of about 825 to 853 calories a day for three to five months, then reintroduced ordinary food in careful steps, then received steady support to keep the weight off. At one year, about 46% of the people in the program were in remission, compared with about 4% of those getting usual care.2 At two years, remission held in about 36%, versus 3% of the comparison group.3
The most telling finding was the link to weight. Remission tracked the pounds lost almost step for step: among people who lost 15 kilograms or more, roughly 33 pounds, about 86% were in remission at one year; in the 10-to-15 kilogram group about 57%; and among those who gained weight, none. That dose-response is the heart of the story, because it shows remission is not random luck but a fairly direct consequence of losing enough weight.
Why does losing weight reverse diabetes?
The leading explanation comes from Roy Taylor's work, and it reframes type 2 diabetes as, for many people, a problem of fat in the wrong places.4 The idea, called the twin cycle hypothesis, is that when a person takes in more energy than their body can store safely under the skin, fat spills into the liver and then the pancreas. Fat in the liver drives up blood sugar; fat in the pancreas quiets the beta cells that make insulin. The two feed each other in a cycle that produces diabetes.
The hopeful corner of this idea is that the process can run backward. Lose enough weight, and fat drains out of the liver and pancreas, and the beta cells, which were suppressed rather than dead, can start making insulin again. Taylor describes a personal fat threshold: each person has a level of fat storage above which their own body crosses into diabetes, and that threshold is individual, which is why some people develop diabetes at a lower weight than others. Getting below your own threshold is what allows remission. This model best explains diabetes caught early; the longer the beta cells have been under strain, the less fully they recover, which is why time matters so much.
How much weight, and who is most likely to succeed?
The amount of weight loss involved is substantial. Remission generally requires losing on the order of 10 to 15 kilograms, roughly 22 to 33 pounds, or about 15% of body weight, and the more that is lost, the more likely remission becomes. The 2026 American Diabetes Association standards make the same point, that weight loss beyond 10% of body weight begins to have disease-modifying effects and can bring remission.5 This is a bigger target than the modest weight loss often suggested for general health, which is part of why remission takes a serious program rather than casual effort.
Some people are far more likely to reach remission than others, and the predictors are consistent. Remission is most achievable early in the disease, often within the first six years of diagnosis, when the beta cells still have reserve. It is more likely in people with a lower starting HbA1c, in those not yet using insulin, and in those who still make a good amount of their own insulin, which can be gauged by a blood test called C-peptide. Needing insulin is the strongest sign that remission will be harder, because it usually means beta-cell capacity has already fallen. None of these rule anyone out, but they shape how realistic the goal is and how hard the push needs to be.
What are the routes to remission?
There is more than one path, and they share the same engine underneath: substantial, sustained weight loss.
The first is an intensive dietary program like the one in DiRECT, using a low-calorie formula diet to produce rapid weight loss, then a careful return to food and long-term maintenance. Its strength is that it was proven in a controlled trial in ordinary practices, and it puts the mechanism, weight loss, to work directly.
The second is carbohydrate restriction. A well-known non-randomized study from a company-run care model reported that a low-carbohydrate program lowered HbA1c substantially and let most people reduce or stop diabetes medication over a year.6 It is encouraging evidence that low-carb eating can drive diabetes control and often what people call reversal, but two cautions belong with it: the study was not randomized and was run by the program's own company, and its definition of success allowed people to stay on metformin, so it does not map neatly onto the strict off-all-medication definition of remission.
The third is metabolic, or bariatric, surgery, which produces large and durable weight loss and high rates of normal blood sugar. In the STAMPEDE trial, far more people reached a near-normal HbA1c after surgery than with medical therapy alone at five years.7 One honest caveat: that trial counted good sugars whether or not the person was still on medication, so its headline numbers describe excellent control rather than the strict off-medication remission, though surgery does often produce true remission as well. Surgery is the most powerful tool for the largest weight loss, with the trade-offs of an operation.
Do Ozempic and Mounjaro put diabetes into remission?
This is where the definition matters most, and where a lot of confusion lives. GLP-1 and dual-agonist drugs like semaglutide and tirzepatide lower blood sugar powerfully and drive major weight loss, and many people on them see their HbA1c fall into the normal range. That is a very good outcome, but by the formal definition it is control rather than remission, because these drugs are themselves glucose-lowering medications, and remission requires normal sugar with no such drug being taken.
The interesting and open question is what happens after. Because these drugs cause so much weight loss, it is plausible that some people could reach true remission if they lost enough weight and then came off the medication with the blood sugar staying normal. So far, though, the honest picture is cautionary: when these drugs are stopped, weight and blood sugar tend to climb back, and durable remission after stopping has not been shown. It is an area of active study rather than a settled promise. So the fair way to hold it is that these drugs are excellent for controlling diabetes and driving the weight loss that remission depends on, but staying at a normal HbA1c while taking one is not the same as remission.
Does remission last?
This is the part that deserves the most candor, because it is where hope meets reality. Remission is achievable, and it is also fragile.
The five-year follow-up of the DiRECT trial tells the honest story.8 Remission occurred and, for some, was durable, but it thinned over time: about 13% of the program group were still in remission at five years, and of the people who were in remission at two years, roughly a quarter were still there at five. The reason is simple: remission lasts as long as the weight loss lasts, and keeping a large amount of weight off for years is very hard. When the weight returns, the fat returns to the liver and pancreas, and the diabetes tends to return with it.
That does not diminish the achievement, but it does define the work. Reaching remission is a project of a few months; keeping it is a project of years, built on maintained weight, steady habits, and continued monitoring. And because remission can slip, the blood sugar still needs to be checked over time even after it normalizes, so that if diabetes starts to return, it is caught early. Remission is best seen not as a finish line but as a state worth defending.
Guidance from the Clinic
Key Takeaways
- Type 2 diabetes can go into remission, defined as an HbA1c below 6.5% sustained for at least three months after stopping all glucose-lowering medication; doctors say remission rather than cure because it can return.
- The DiRECT trial proved it: a structured weight-loss program produced remission in about 46% at one year, and the odds rose with weight lost, reaching about 86% among those who lost 15 kilograms or more.
- The mechanism is weight loss clearing fat from the liver and pancreas, letting the body make its own insulin again; each person has a personal fat threshold to get below.
- Remission usually requires losing about 10 to 15 kilograms or roughly 15% of body weight, and is most likely early in the disease, with a lower HbA1c, without insulin, and with preserved insulin production.
- Normal blood sugar while taking a drug like Ozempic is control rather than remission; and remission is not permanent, fading to about 13% at five years in DiRECT, so maintained weight and ongoing monitoring are essential. This applies to type 2 diabetes, not type 1.
Related at Fishtown Medicine
- Metabolic Health and Insulin Resistance - the root process underneath type 2 diabetes
- Ozempic vs Metformin - the drugs used to control diabetes, and where they fit
- Medical Weight Loss and Body Composition - the engine of remission, done durably
- GLP-1 Drugs vs Bariatric Surgery - two of the routes to major weight loss, compared
- Fasting Protocols - one dietary approach to the weight loss remission depends on
Scientific References
- Riddle MC, Cefalu WT, Evans PH, et al. "Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes." Diabetes Care. 2021;44(10):2438-2444.
- Lean MEJ, Leslie WS, Barnes AC, et al. "Primary Care-Led Weight Management for Remission of Type 2 Diabetes (DiRECT): An Open-Label, Cluster-Randomised Trial." The Lancet. 2018;391(10120):541-551.
- Lean MEJ, Leslie WS, Barnes AC, et al. "Durability of a Primary Care-Led Weight-Management Intervention for Remission of Type 2 Diabetes: 2-Year Results of the DiRECT Open-Label, Cluster-Randomised Trial." The Lancet Diabetes & Endocrinology. 2019;7(5):344-355.
- Taylor R. "Type 2 Diabetes and Remission: Practical Management Guided by Pathophysiology." Journal of Internal Medicine. 2021;289(6):754-770.
- American Diabetes Association Professional Practice Committee. "Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026." Diabetes Care. 2026;49(Supplement 1):S166-S182.
- Hallberg SJ, McKenzie AL, Williams PT, et al. "Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study." Diabetes Therapy. 2018;9(2):583-612.
- Schauer PR, Bhatt DL, Kirwan JP, et al. "Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes." New England Journal of Medicine. 2017;376(7):641-651.
- Lean MEJ, Leslie WS, Barnes AC, et al. "5-Year Follow-up of the Randomised Diabetes Remission Clinical Trial (DiRECT) of Continued Support for Weight Loss Maintenance." The Lancet Diabetes & Endocrinology. 2024;12(4):233-246.
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Ready when you are
Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.





